Bristol-Myers Escapes $3.4B Apotex Suit Over Plavix Deal
Bristol-Myers Squibb Co. and partner Sanofi-Aventis SA won a defense verdict Wednesday in a $3.4 billion suit in which generic-drug maker Apotex Inc. alleged the companies breached a patent litigation settlement...To view the full article, register now.
Already a subscriber? Click here to view full article